Inhibitors of her3 activity
CA 2456723 C · Owner: Ullrich, Axel · Inventors: Htun-Van Der Horst, Edward; Ullrich, Axel
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a pharmaceutical composition comprising as an active agent an inhibitor of HER3 activity particularly an anti-HER3- , antibody. Further the use of this composition for the diagnosis prevention , or treatment of hyperproliferative diseases particularly tumor diseases is , disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 9, 2002 and granted February 9, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.